Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Fenimore Christopher R.
SVP Finance & CFO at Regeneron Pharmaceuticals. Filing since 20 Dec 2018.
CIK 0001697422
Company
Date
Role
Action
Shares
Amount
Of holding
REGN
Regeneron Pharmaceuticals
28 Aug 2024
SVP Finance & CFO
Sold at will
5,680
$6.85M
100%
REGN
Regeneron Pharmaceuticals
9 Feb 2024
SVP Finance & CFO
Sold at will
4,919
$4.69M
25.5%
REGN
Regeneron Pharmaceuticals
27 Dec 2023
SVP Controller
Sold on a plan
2,448
$2.10M
14.6%
REGN
Regeneron Pharmaceuticals
22 Dec 2023
SVP Controller
Sold on a plan
250
$211.57K
1.5%
REGN
Regeneron Pharmaceuticals
21 Dec 2023
SVP Controller
Sold on a plan
1,680
$1.42M
9.0%
REGN
Regeneron Pharmaceuticals
23 Mar 2023
SVP Controller
Sold on a plan
2,192
$1.77M
10.6%
REGN
Regeneron Pharmaceuticals
5 Oct 2022
SVP Controller
Sold, plan not stated
1,844
$1.38M
10.1%
REGN
Regeneron Pharmaceuticals
3 Oct 2022
SVP Controller
Sold, plan not stated
3,346
$2.42M
15.5%
REGN
Regeneron Pharmaceuticals
23 Aug 2021
SVP Controller
Sold, plan not stated
4,781
$3.13M
14.7%
REGN
Regeneron Pharmaceuticals
21 Jul 2020
VP Controller
Sold, plan not stated
3,709
$2.38M
17.5%
REGN
Regeneron Pharmaceuticals
16 Jun 2020
VP Controller
Sold, plan not stated
3,556
$2.10M
18.9%
REGN
Regeneron Pharmaceuticals
1 Apr 2020
VP Controller
Sold, plan not stated
1,200
$586.10K
8.4%
REGN
Regeneron Pharmaceuticals
13 Dec 2019
VP Controller
Sold, plan not stated
1,682
$632.66K
12.1%
REGN
Regeneron Pharmaceuticals
20 Dec 2018
VP Controller
Sold, plan not stated
1,848
$663.38K
20.7%
14 decisions on file.
